Takeda Pharmaceutical Company Limited Adjustments For Increase Decrease In Other Liabilities
Takeda Pharmaceutical Company Limited (TAK) reported Adjustments For Increase Decrease In Other Liabilities of -JPY 3.49 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities · last filed 2025-06-25
| Period end | Adjustments For Increase Decrease In Other Liabilities 12 month |
|---|---|
| 2025-03-31 | -3.49B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | -18.57B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 31.67B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | -49.61B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 173.40B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 7.16B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -4.01B JPY 20-F · filed 2021-06-29 |